"Promote and safeguard the health & well-being of the patient"
Subcommittee of Site Monitoring
Chair: Professor Dr Kiew Lik Voon
Prof. Dr. Kiew Lik Voon obtained his Ph.D. degree in Biopolymer Technology and Therapeutics from the Universiti Malaya, Malaysia.
His research interests and expertise are in the development of nano-sized complexes and particles for anticancer and organ-selective drug delivery and therapy. He also evaluates synthetic and bioactive compounds/materials for toxicity, physiology impact and disease treatment efficacy. He also assesses the acute and chronic impacts of intravenous administration of nano-drug-carriers and nanotherapeutics
to the cardiovascular physiology of rats using radio-telemetry techniques.
Prof. Dr. Kiew is currently a Professor and the Head of the Department of Pharmacology, Faculty of Medicine, Universiti Malaya (UM), Malaysia. He has 15 years of experience as a pharmacologist and pharmacology educator.
Subcommittee of Serious Adverse Event
Chair: Ms Wong Yin Yen
Ms Wong Yin Yen is currently the Manager (Clinical) at the Clinical Investigation Centre (CIC), Universiti Malaya Medical Centre (UMMC). She obtained her Bachelor of Pharmacy from Universiti Sains Malaysia (USM) in 2005 and previously served as a drug information pharmacist at UMMC.
​
She serves as the Chairperson of the Serious Adverse Event (SAE) Subcommittee at UMMC, overseeing the review and monitoring of serious adverse events in clinical research to ensure participant safety and regulatory compliance. She also contributes to the Medical Research and Ethics Committee (MREC) as a Scientific Reviewer, supporting the ethical and scientific assessment of research protocols.
​
In her current role at CIC, she is actively involved in clinical research governance, safety oversight, and coordination of clinical trials, helping to strengthen research quality and compliance at UMMC.
